Chula Executives Visit Amgen Inc., a Leading U.S. Biotechnology Company, to Explore Future Academic Collaboration

On June 4, 2025, a delegation of executives from Chulalongkorn University, led by the Vice President, Assistant to the President, and other executives from various faculties, colleges, and institutes, visited Amgen Inc., a leading U.S.-based biotechnology company operating on a global scale. Amgen focuses on the development of biologic medicines and biosimilars used in the treatment of cancer, kidney disease, and autoimmune disorders.

During the visit, Amgen Inc. presented an overview of its research and development strategies, biomanufacturing processes, and global collaborations. The Chulalongkorn University executives also toured Amgen’s manufacturing facilities and operations.

This visit to one of the top biotechnology companies in the United States provided an opportunity for Chulalongkorn University and Amgen Inc. to discuss potential academic and industrial collaborations in the future.